IN188843B - - Google Patents

Info

Publication number
IN188843B
IN188843B IN223MU2000A IN188843B IN 188843 B IN188843 B IN 188843B IN 223MU2000 A IN223MU2000 A IN 223MU2000A IN 188843 B IN188843 B IN 188843B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Srikanth Annappa Pai
Sangeeta Hanurmesh Rivankar
Shilpa Sudhakar Kocharekar
Original Assignee
Vinod Daftary Gautam Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vinod Daftary Gautam Dr filed Critical Vinod Daftary Gautam Dr
Priority to IN223MU2000 priority Critical patent/IN188843B/en
Priority to RU2003101391/04A priority patent/RU2275899C2/ru
Priority to JP2002503255A priority patent/JP4804702B2/ja
Priority to AU8008401A priority patent/AU8008401A/xx
Priority to AT01958366T priority patent/ATE355825T1/de
Priority to EP01958366A priority patent/EP1313449B1/fr
Priority to US10/312,298 priority patent/US7053061B2/en
Priority to ES01958366T priority patent/ES2283423T3/es
Priority to DE60127140T priority patent/DE60127140T2/de
Priority to AU2001280084A priority patent/AU2001280084B2/en
Priority to PCT/IN2001/000119 priority patent/WO2001097778A2/fr
Priority to CNB018143318A priority patent/CN100502834C/zh
Priority to KR1020027017441A priority patent/KR100812764B1/ko
Publication of IN188843B publication Critical patent/IN188843B/en
Priority to ZA200300330A priority patent/ZA200300330B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
IN223MU2000 2000-06-22 2000-06-22 IN188843B (fr)

Priority Applications (14)

Application Number Priority Date Filing Date Title
IN223MU2000 IN188843B (fr) 2000-06-22 2000-06-22
ES01958366T ES2283423T3 (es) 2000-06-22 2001-06-19 Emulsion estructurada de anfotericina b.
DE60127140T DE60127140T2 (de) 2000-06-22 2001-06-19 Amphotericin b enthaltende strukturierte emulsion
AU8008401A AU8008401A (en) 2000-06-22 2001-06-19 Amphotericin b structured emulsion
AT01958366T ATE355825T1 (de) 2000-06-22 2001-06-19 Amphotericin b enthaltende strukturierte emulsion
EP01958366A EP1313449B1 (fr) 2000-06-22 2001-06-19 Emulsion structuree d'amphotericine b
US10/312,298 US7053061B2 (en) 2000-06-22 2001-06-19 Amphotercin B structured emulsion
RU2003101391/04A RU2275899C2 (ru) 2000-06-22 2001-06-19 Структурированная эмульсия амфотерицина b с низкой токсичностью для парентерального введения и способ ее получения
JP2002503255A JP4804702B2 (ja) 2000-06-22 2001-06-19 アムホテリシンｂ構造化エマルション
AU2001280084A AU2001280084B2 (en) 2000-06-22 2001-06-19 Amphotericin b structured emulsion
PCT/IN2001/000119 WO2001097778A2 (fr) 2000-06-22 2001-06-19 Emulsion structuree d'amphotericine b
CNB018143318A CN100502834C (zh) 2000-06-22 2001-06-19 两性霉素b结构化乳剂
KR1020027017441A KR100812764B1 (ko) 2000-06-22 2001-06-19 구조화된 암포테리신 ｂ 유제
ZA200300330A ZA200300330B (en) 2000-06-22 2003-01-13 Amphotericin B Structured emulsion.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN223MU2000 IN188843B (fr) 2000-06-22 2000-06-22

Publications (1)

Publication Number Publication Date
IN188843B true IN188843B (fr) 2002-11-09

Family

ID=11097226

Family Applications (1)

Application Number Title Priority Date Filing Date
IN223MU2000 IN188843B (fr) 2000-06-22 2000-06-22

Country Status (13)

Country Link
US (1) US7053061B2 (fr)
EP (1) EP1313449B1 (fr)
JP (1) JP4804702B2 (fr)
KR (1) KR100812764B1 (fr)
CN (1) CN100502834C (fr)
AT (1) ATE355825T1 (fr)
AU (2) AU8008401A (fr)
DE (1) DE60127140T2 (fr)
ES (1) ES2283423T3 (fr)
IN (1) IN188843B (fr)
RU (1) RU2275899C2 (fr)
WO (1) WO2001097778A2 (fr)
ZA (1) ZA200300330B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA200700440A1 (ru) * 2004-09-13 2008-02-28 Бхарат Сирумс Энд Вэксинс Лтд. Композиции стабильных эмульсий для внутривенного введения, имеющие защитную эффективность
RU2485975C2 (ru) * 2007-05-25 2013-06-27 Дзе Юниверсити Оф Бритиш Коламбиа Составы для перорального введения лекарственных средств и родственные способы
US9750812B2 (en) * 2008-09-27 2017-09-05 Jina Pharmaceuticals, Inc. Lipid based pharmaceutical preparations for oral and topical application; their compositions, methods, and uses thereof
US20100209512A1 (en) * 2009-02-13 2010-08-19 Stable Solutions Llc Particle size-structured parenteral dispersions
WO2011050457A1 (fr) 2009-10-26 2011-05-05 The University Of British Columbia Formulation stabilisée pour administration orale d'agents thérapeutiques et méthodes afférentes

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4707470A (en) * 1985-05-17 1987-11-17 Smithkline Beckman Corporation Polyene antibiotic emulsion formulation
GB8714652D0 (en) * 1987-06-23 1987-07-29 Davis S S Drug emulsion
AU614465B2 (en) * 1989-04-05 1991-08-29 Yissum Research Development Company Of The Hebrew University Of Jerusalem Medicinal emulsions
US5364632A (en) * 1989-04-05 1994-11-15 Yissum Research Development Company Of The Hebrew University Of Jerusalem Medicinal emulsions
GB8919172D0 (en) * 1989-08-23 1989-10-04 Univ Nottingham Useful composition
JPH04173736A (ja) * 1990-11-06 1992-06-22 Nippon Shinyaku Co Ltd 乳化剤
US5534502A (en) * 1990-11-06 1996-07-09 Nippon Shinyaku Co. Ltd. Process for producing fat emulsion
GB9426104D0 (en) * 1994-12-23 1995-02-22 Merck Sharp & Dohme Use of surfactants and emulsions
JPH1160491A (ja) * 1997-08-25 1999-03-02 Yoshitomi Pharmaceut Ind Ltd アムホテリシンｂ含有製剤
DE10036871A1 (de) * 2000-07-28 2002-02-14 Pharmasol Gmbh Dispersionen zur Formulierung wenig oder schwer löslicher Wirkstoffe

Also Published As

Publication number Publication date
EP1313449B1 (fr) 2007-03-07
KR20030039331A (ko) 2003-05-17
JP2004525068A (ja) 2004-08-19
US7053061B2 (en) 2006-05-30
WO2001097778A3 (fr) 2002-05-30
RU2275899C2 (ru) 2006-05-10
ES2283423T3 (es) 2007-11-01
DE60127140T2 (de) 2007-12-13
CN100502834C (zh) 2009-06-24
WO2001097778A2 (fr) 2001-12-27
DE60127140D1 (de) 2007-04-19
KR100812764B1 (ko) 2008-03-12
US20030206929A1 (en) 2003-11-06
AU8008401A (en) 2002-01-02
CN1447682A (zh) 2003-10-08
WO2001097778A8 (fr) 2003-06-26
ZA200300330B (en) 2004-04-08
ATE355825T1 (de) 2007-03-15
EP1313449A2 (fr) 2003-05-28
JP4804702B2 (ja) 2011-11-02
AU2001280084B2 (en) 2005-11-17

Similar Documents

Publication Publication Date Title
BE2017C009I2 (fr)
BE2016C018I2 (fr)
BE2014C035I2 (fr)
LU91681I9 (fr)
BE2010C008I2 (fr)
JP2000284937A5 (fr)
AU2000236815A8 (fr)
BRPI0110940B8 (fr)
JP2002536987A5 (fr)
JP2002535763A5 (fr)
AR028236A3 (fr)
BE2014C025I2 (fr)
JP2002144267A5 (fr)
JP2002076136A5 (fr)
JP2002132038A5 (fr)
JP2002126599A5 (fr)
IN188843B (fr)
JP2002182272A5 (fr)
JP2002064760A5 (fr)
JP2002128165A5 (fr)
JP2002188246A5 (fr)
IN190478B (fr)
JP2002189337A5 (fr)
BRPI0003419A (fr)
IN189049B (fr)